Now Available – Webinars
Access our free on-demand webinars covering topics across osmolality within bioprocessing and clinical chemistry.
OSMOLALITY TESTING CAN HELP WITH EARLY DIAGNOSIS AND ETIOLOGICAL DETERMINATION OF HYPONATREMIA, WHICH IS CRITICAL FOR THIS PATIENT POPULATION.
Article Summary: Recent publications have shown that COVID-19 (coronavirus disease 2019), an infectious disease caused by a novel coronavirus known as severe acute respiratory syndrome coronavirus (SARS-CoV-2), is associated with electrolyte disorders including hyponatremia. Early diagnosis and etiologic determination are critical in any hyponatremic patient to ensure proper treatment and to avoid potential harm to the patient. Osmolality testing is quick, inexpensive and effective to help with early detection and diagnosis of hyponatremia. Osmolality testing can help ensure that appropriate treatment strategies are implemented early for hyponatremic patients which may be even more significant in patients hospitalized with COVID-19. As clinicians and researchers continue to expand their understanding of COVID-19, additional laboratory testing is important to consider to help better understand and diagnose a COVID-19 patient’s underlying conditions.
For inquiries, please contact:
Lisa Fahey, Director of Marketing, [email protected]
2 Technology Way
Norwood, MA 02062